+49 711 500 989 80
deen

Engineered nanomaterial captures off-target cancer drug to prevent tissue damage



Engineered nanomaterial captures off-target cancer drug to prevent tissue damage

Standard chemotherapies may efficiently kill cancer cells, but they also pose significant risks to healthy cells, resulting in secondary illness and a diminished quality of life for patients. To prevent the previously unavoidable damage, researchers have developed a new class of nanomaterials engineered to capture chemotherapy drugs before they interact with healthy tissue.

Materials provided by Penn State. Original written by Ashley Wenners Herron. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

16th January 2022

MAPK4 emerges as a novel therapeutic target for triple-negative breast cancer

Read more
16th January 2022

Nuclei-free cells prove utility in delivering therapeutics to diseased tissues

Read more
15th January 2022

Blood test helps predict who may benefit from lung cancer screening

Read more